Pharmaceutical drug design using dynamic connectionist ensemble Networks

, &
In S. Iwata, Y. Oshawa, S. Tsumoto, N. Zhong, Y. Shi & L. Magnani (eds.), Communications and Discoveries From Multidisciplinary Data. Springer. pp. 221--231 (2008)
  Copy   BIBTEX

Abstract

This article has no associated abstract. (fix it)

Categories

Keywords

Reprint years

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 91,386

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

My notes

Similar books and articles

Integrating research and development: the emergence of rational drug design in the pharmaceutical industry.Matthias Adam - 2005 - Studies in History and Philosophy of Science Part C: Studies in History and Philosophy of Biological and Biomedical Sciences 36 (3):513-537.
Connectionist, symbolic, and the brain.Paul Smolensky - 1987 - AI Review 1:95-109.
The connectionist framework for Gene regulation.Roger Sansom - 2008 - Biology and Philosophy 23 (4):475-491.
What is connectionism?Istvan S. N. Berkeley - manuscript
From centrality to temporary fame: Dynamic centrality in complex networks.Dan Braha & Yaneer Bar-Yam - 2006 - Complexity 12 (2):59-63.
The changing significance of chance experiments in technological development.Matthias Adam - manuscript
How do connectionist networks compute?Gerard O'Brien & Jonathan Opie - 2006 - Cognitive Processing 7 (1):30-41.
Networks: open, closed or complex. Connecting philosophy, design and innovation, part 3.Jamie Brassett - unknown
Five Un‐Easy Pieces of Pharmaceutical Policy Reform.Marc A. Rodwin - 2013 - Journal of Law, Medicine and Ethics 41 (3):581-589.
Pharmaceutical advertisements: How they deceive patients. [REVIEW]Ashish Chandra & Gary A. Holt - 1999 - Journal of Business Ethics 18 (4):359 - 366.
Ethical considerations in the use of direct-to-consumer advertising and pharmaceutical promotions: The impact on pharmaceutical sales and physicians. [REVIEW]R. Stephen Parker & Charles E. Pettijohn - 2003 - Journal of Business Ethics 48 (3):279-290.
Ethical Issues in New Drug Prescribing.Lindsay W. Cole, Jennifer C. Kesselheim & Aaron S. Kesselheim - 2012 - Journal of Bioethical Inquiry 9 (1):77-83.
Drugs, Money, and Power: The Canadian Drug Shortage.Chris Kaposy - 2014 - Journal of Bioethical Inquiry 11 (1):85-89.

Analytics

Added to PP
2014-01-26

Downloads
13 (#1,010,467)

6 months
2 (#1,232,442)

Historical graph of downloads
How can I increase my downloads?

Citations of this work

No citations found.

Add more citations

References found in this work

No references found.

Add more references